Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. Molavi
Cardioprotective Effects of Rosiglitazone Are Associated With Selective Overexpression of Type 2 Angiotensin Receptors and Inhibition of P42/44 MAPK
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Related publications
Simultaneous Activation of P38 MAPK and P42/44 MAPK by ATP Stimulates the K+Current ITREKin Cardiomyocytes
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Angiotensin II Type 2 Receptor Gene Transfer Elicits Cardioprotective Effects in an Angiotensin II Infusion Rat Model of Hypertension
Physiological Genomics
Genetics
Physiology
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists in Rats With Heart Failure. Role of Kinins and Angiotensin II Type 2 Receptors.
Journal of Clinical Investigation
Medicine
Moderate Cardiac-Selective Overexpression of Angiotensin II Type 2 Receptor Protects Cardiac Functions From Ischaemic Injury
Experimental Physiology
Nutrition
Physiology
Dietetics
Overexpression of Type 1 Angiotensin II Receptors Impairs Excitation-Contraction Coupling in the Mouse Heart
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Divergent Effects of Corticotropin Releasing Hormone on Endothelial Cell Nitric Oxide Synthase Are Associated With Different Expression of CRH Type 1 and 2 Receptors
British Journal of Pharmacology
Pharmacology
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Can Angiotensin II Type 2 Receptors Have Deleterious Effects in Cardiovascular Disease?: Implications for Therapeutic Blockade of the Renin-Angiotensin System
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Angiotensin Type 2 Receptors: Blood Pressure Regulation and End Organ Damage
Current Opinion in Pharmacology
Drug Discovery
Pharmacology
